Blood tests that detect early cancer are coming to market. Could they lead to earlier diagnosis and treatment?

Gormly was one of the first patients to take a newly approved test called Shield, which its makers say can detect colon cancer from a blood sample ... a colonoscopy or a stool-based test, every ...

The firm's next-generation pancreatic cancer test looks for five biomarkers that are indicative of early-stage disease.

In the seriously great news department, pancreatic cancer is expected to pass colorectal cancer as the second biggest cause of cancer-related death by 2030. Yes, it’s great news. To see why ...

Patients with pancreatic cancer have an overall poor prognosis: in most patients, the disease has already spread at the time of diagnosis, resulting in limited treatment options. Nearly 90 percent ...

A consistent and dependable source of samples for metagenomics analysis or microbial detection using NGS, qPCR, ddPCR, and other techniques. Figure 2. Integrity of Total Stool DNA and RNA Isolated ...

“I had a mass on my pancreas,” he says. “The doctor there was not ready to tell me I had pancreatic cancer.” The following day, he underwent an MRI, and by that evening, doctors had ...

Despite progress in treatments for various cancers, pancreatic cancer continues to pose a significant challenge, with the NHS admitting that it "can be difficult to treat". Early detection is ...

CINCINNATI (WKRC) — Researchers are conducting a groundbreaking trial that could revolutionize the way the body fights cancer, particularly for those living with pancreatic cancer. This trial is ...